3 Agents to Watch for Decompensated Cirrhosis from NASH
HepaStem, BIV201, and Albutein are late-stage pipeline agents in development for NASH, focusing specifically on decompensated cirrhosis.
Source: hcplive.com
Stay updated with breaking news from Ascites Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HepaStem, BIV201, and Albutein are late-stage pipeline agents in development for NASH, focusing specifically on decompensated cirrhosis.